Clinical trials
Attention Deficit clinical trials
Below are recruiting attention deficit clinical trials, each written for real people, not researchers. We’re tracking 131 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07037030Enrolling by invitation
Mindfulness for ADHD in children
This study tests a mindfulness program designed to help children ages 7 to 11 with ADHD improve focus and manage symptoms. It may be a good option if you're looking for a non-medication approach.
Brookline, MassachusettsAges 7–11 - NCT06931080RecruitingPhase 2/Phase 3
Study of EB-1020 for adults with ADHD
This trial tests a new medication called EB-1020 for adults with ADHD. It aims to see if the drug is safe and effective in improving ADHD symptoms. You may be able to join if you have a clear ADHD diagnosis and your symptoms are moderate to severe.
TokyoAges 18–55 - NCT06926829RecruitingPhase 3
Long-term study of EB-1020 for adults with ADHD
This trial is for adults with ADHD who completed a previous study of the drug EB-1020. It tests the long-term safety and effectiveness of the medication over an extended period.
TokyoAges 18–55 - NCT06900673Enrolling by invitationEarly Phase 1
ADHD support program for families and schools
This study tests a technology-based program to help teachers and parents better support children with ADHD. It aims to make proven treatments more accessible for families in need.
San Diego, CaliforniaAges 7 years+ - NCT06792175Enrolling by invitation
Using speech to detect mental health conditions
This study uses a computer program to listen to your speech and see if it can help detect mental health or neurodevelopmental conditions. It may help find new ways to diagnose conditions like ADHD, anxiety, depression, and others earlier.
Brookline, MassachusettsAges 13–60 - NCT05301361Enrolling by invitationPhase 1
Test of brain testing during stimulant treatment for ADHD
This trial checks whether a “NIH Toolbox” set of child-friendly tests can detect changes when stimulant medicine is used for ADHD. It may help doctors better measure how well stimulant treatment is working in people with intellectual disability.
Sacramento, CaliforniaAges 6–24 - NCT05859126Enrolling by invitation
Choline supplement study on teens’ learning and thinking
This study follows children of mothers who previously took a choline supplement, and it tests how those children think and learn when they reach age 13. It looks at whether earlier choline intake during pregnancy is linked to better or different thinking skills in adolescence.
Ithaca, New YorkAges 13–13 - NCT06615115Recruiting
Focus instructions for balance in Parkinson's rehab
This study looks at whether different types of instructions (like focusing on your movements) can help improve balance for people with Parkinson's. It might help you move better and feel more steady.
IstanbulAges 50–70 - NCT07226219RecruitingPhase 1
Methylphenidate for Attention in Sickle Cell Disease
This trial tests if a medication called methylphenidate can help children with sickle cell disease who have trouble with attention, focus, or executive function. It aims to see if it can improve daily life and school performance.
Memphis, TennesseeAges 8–17 - NCT06981351Recruiting
Matching addiction treatment to thinking skills in prison
This trial tests whether matching treatment to specific thinking and learning problems can help people in prison who have struggled with drugs or alcohol. If you join, you may get a program designed just for your needs.
Albuquerque, New MexicoAges 18–55 - NCT06501495Recruiting
Brain waves and memory in aging and Alzheimer's
This study looks at how brain waves (EEG) change during normal aging and early Alzheimer's disease. It compares three groups: people with early-stage Alzheimer's, healthy older adults, and healthy young adults. The goal is to understand how memory and thinking problems relate to slow brain wave activity.
ParisAges 18–85
Hear when a new Attention Deficit trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for attention deficit?
- Yes. Clin2 currently lists 131 recruiting attention deficit studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a attention deficit trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a attention deficit trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.